Skip to main content
. Author manuscript; available in PMC: 2018 Mar 15.
Published in final edited form as: Int J Pharm. 2017 Jan 16;519(1-2):145–156. doi: 10.1016/j.ijpharm.2017.01.020

Fig. 10.

Fig. 10

Cell viability following treatment with free unmodified and PEGylated vitamin E isomers against the non-tumorigenic hTERT-HME human breast cells. Cells were treated for 72 h. Values reported are the mean ± SD for triplicate samples.